What is the CVSS score of CVE-2024-24245?

CVE-2024-24245 has a CVSS 3.1 base score of 7.8 (High). CVSS vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H. EPSS exploitation probability: 0.2%.

Clamxav CVE-2024-24245

HIGH

Execution with Unnecessary Privileges (CWE-250)

2024-04-09 cve@mitre.org

Privilege Escalation Clamxav

7.8

CVSS 3.1 · Vendor: mitre

Severity by source

Vendor (mitre) PRIMARY

7.8 HIGH

AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Primary rating from Vendor (mitre) · only source for this CVE.

CVSS VectorVendor: mitre

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Attack Vector

Local

Attack Complexity

Low

Privileges Required

Low

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

Apr 09, 2024 - 19:15 cve.org

HIGH 7.8

DescriptionCVE.org

An issue in Canimaan Software LTD ClamXAV v3.1.2 through v3.6.1 and fixed in v.3.6.2 allows a local attacker to escalate privileges via the ClamXAV helper tool component.

AnalysisAI

An issue in Canimaan Software LTD ClamXAV v3.1.2 through v3.6.1 and fixed in v.3.6.2 allows a local attacker to escalate privileges via the ClamXAV helper tool component. Rated high severity (CVSS 7.8), this vulnerability is low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-250. An issue in Canimaan Software LTD ClamXAV v3.1.2 through v3.6.1 and fixed in v.3.6.2 allows a local attacker to escalate privileges via the ClamXAV helper tool component. Affected products include: Clamxav.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.